BioAssay Works Overview
- Founded
-
2005

- Status
-
Private
- Employees
-
12

- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$160K
- Investors
-
1
BioAssay Works General Information
Description
Developer of nanoparticle gold products intended for immunodetection products and services. The company's nanoparticle gold products include crucial reagents, such as gold sols, gold conjugates and gold ribbons, that are the backbone of any high-performance lateral-flow device.
Contact Information
Website
www.bioassayworks.com
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Diagnostic Equipment
Primary Office
- 10075 Tyler Place
- Suite 18
- Ijamsville, MD 21754
- United States
+1 (301) 000-0000
BioAssay Works Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Debt - PPP | 07-Apr-2020 | $160K | Completed | Generating Revenue | ||
1. Grant | 19-Jul-2009 | 0000 | Completed | Generating Revenue |
BioAssay Works Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of nanoparticle gold products intended for immunodetection products and services. The company's nanoparticle g
Discovery Tools (Healthcare)
Ijamsville, MD
12
As of 2023
000000000 -
BioAssay Works Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
DCN Diagnostics | Private Equity-Backed | Carlsbad, CA | 00 | 0000000 0000 | ||
000 00000000000 | Corporation | Warsaw, Poland | 00 | 000.00 | 00000000 | 000.00 |
BioAssay Works Patents
BioAssay Works Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-8153444-B2 | Immuno gold lateral flow assay | Active | 13-Oct-2005 | 000000000000 | 00 |
US-20090246804-A1 | Immuno gold lateral flow assay | Active | 13-Oct-2005 | 000000000000 | |
US-7910381-B2 | Chromatographic binding permeable membrane strip containing capture reagent site and reservoir pad; colored conjugate; capillary action; rapid, high sensitivity, detecting low levels of ligands | Active | 13-Oct-2005 | 000000000000 | |
US-20080188009-A1 | Chromatographic binding permeable membrane strip containing capture reagent site and reservoir pad; colored conjugate; capillary action; rapid, high sensitivity, detecting low levels of ligands | Active | 13-Oct-2005 | G01N33/54386 |
BioAssay Works Executive Team (4)
BioAssay Works Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Landon Weeks MD | BioAssay Works | Chairman | 000 0000 |
Stephen Mefferd | BioAssay Works | Co-founder, Founding Partner, Board Member & President | 000 0000 |
BioAssay Works Signals
BioAssay Works Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 |